1. Antioxidant Effects of Resveratrol in Intervertebral Disk
- Author
-
Sidong Yang, Yibo Zhu, Ji Tu, Yachong Huo, Kaitao Lai, Da-Long Yang, and Wenyuan Ding
- Subjects
Antioxidant ,medicine.medical_treatment ,Inflammation ,Intervertebral Disc Degeneration ,Pharmacology ,Resveratrol ,medicine.disease_cause ,Antioxidants ,chemistry.chemical_compound ,In vivo ,medicine ,Humans ,Intervertebral Disc ,chemistry.chemical_classification ,Reactive oxygen species ,business.industry ,Autophagy ,food and beverages ,Intervertebral disk ,chemistry ,Surgery ,medicine.symptom ,Reactive Oxygen Species ,business ,Oxidative stress - Abstract
Intervertebral disk (IVD) degeneration (IVDD) can cause various spinal degenerative diseases. Cumulative evidence has indicated that IVDD can result from inflammation, apoptosis, autophagy, biomechanical changes and other factors. Currently, lack of conservative treatment for degenerative spinal diseases leads to an urgent demand for clinically applicable medication to ameliorate the progression of IVDD. Resveratrol (3,5,4'-trihydroxy-trans-stilbene), a polyphenol compound extracted from red wine or grapes, has shown protective effects on IVD, alleviating the progression of IVDD. Resveratrol has been demonstrated as a scavenger of free radicals both in vivo and in vitro. The antioxidant effects of resveratrol are likely attributed to its regulation on mitochondrial dysfunction or the elimination of reactive oxygen species. This review will summarize the mechanisms of the reactive oxygen species production and elaborate the mechanisms of resveratrol in retarding IVDD progression, providing a comprehensive understanding of the antioxidant effects of resveratrol in IVD.
- Published
- 2021
- Full Text
- View/download PDF